Diabetic Foot Ulcer Treatment Market Report 2026

Diabetic Foot Ulcer Treatment Market Overview

• Diabetic Foot Ulcer Treatment market size has reached to $7.94 billion in 2025 • Expected to grow to $11.96 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Diabetes Cases Fuel Expansion In Diabetic Foot Ulcer Treatment Market • Market Trend: Game-Changing On101 Cream Revolutionizes Diabetic Foot Ulcer Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diabetic Foot Ulcer Treatment Market?

Diabetic foot ulcer refers to skin soreness with full-thickness skin loss on the foot due to neuropathic and vascular complications in patients suffering from diabetes mellitus, which slowdowns the healing process of sores and makes it prone to infection. Diabetic foot ulcer treatment is used to prevent, treat, and manage foot ulcers caused in diabetic patients to avoid amputation if neglected. The main types of diabetic foot ulcer treatment are wound care dressings, biologics, therapy devices, antibiotic medications, and other treatments. Wound care dressings refer to a sterile pad that is used to cover wounds to promote healing and protect them from further damage. Wound care dressings are used to protect wounds to encourage a faster healing process. The main types of ulcer are neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcer categorized as grade 1, grade 2, grade 3, grade 4, and grade 5. The diabetic foot ulcer treatment is used by hospital, ambulatory surgery centre, and other end-users.

What Is The Diabetic Foot Ulcer Treatment Market Growth Forecast?

The diabetic foot ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $11.96 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to advancements in biologic therapies, increased use of npwt devices, expansion of multidisciplinary care models, growing focus on early intervention, rising investment in wound care innovation. Major trends in the forecast period include rising adoption of advanced wound care dressings, increased use of biologic therapies, growing demand for combination treatment approaches, expansion of therapy device-based treatments, increasing focus on limb salvage strategies.

Global Diabetic Foot Ulcer Treatment Market Segmentation

1) By Treatment: Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Other Treatments 2) By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers 3) By Grade: Grade 1, Grade 2, Grade 3, Grade 4, Grade 5 4) By End-User: Hospital, Ambulatory Surgery Centre, Other End-Users Subsegments: 1) By Wound Care Dressings: Hydrogels, Foam Dressings, Alginates, Antimicrobial Dressings 2) By Biologics: Growth Factors, Skin Substitutes, Cellular Therapies 3) By Therapy Devices: Negative Pressure Wound Therapy (NPWT) Devices, Electrical Stimulation Devices, Hyperbaric Oxygen Therapy Devices 4) By Antibiotic Medications: Topical Antibiotics, Systemic Antibiotics 5) By Other Treatments: Debridement Procedures, Compression Therapy, Offloading Devices

What Is The Driver Of The Diabetic Foot Ulcer Treatment Market?

The increasing number of diabetes patients is expected to propel the growth of the diabetic foot ulcer treatment market going forward. Diabetes is a metabolic illness with a long-term course that causes elevated blood glucose levels and, over time, causes substantial harm to the heart, blood vessels, eyes, kidneys, and nerves. Diabetes is the leading cause of foot ulcers, leading to an increased demand for diabetic foot ulcer treatment. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based international not-for-profit federation of national diabetes associations, an estimated 589 million adults aged 20-79 were living with diabetes worldwide, with that number projected to reach 853 million by 2050. Therefore, the increased number of diabetes patients is driving the growth of the diabetic foot ulcer treatment industry.

Key Players In The Global Diabetic Foot Ulcer Treatment Market

Major companies operating in the diabetic foot ulcer treatment market are Coloplast A/S, Medtronic PLC, Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., ConvaTec Inc., Acelity L.P. Inc., 3M Healthcare, Smith & Nephew PLC, Organogenesis Inc., BSN Medical GMBH, Integra LifeSciences Corporation, Derma Sciences Inc., Advancis Medical, Tissue Regenix Group PLC, MiMedx Group Inc., Kerecis, Human Regenerative Technologies LLC, AOTI Inc., Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical, L&R USA Inc., Misonix Inc., Bioventus, Cellumed Co. Ltd.

Global Diabetic Foot Ulcer Treatment Market Trends and Insights

Major companies operating in the diabetic foot ulcer treatment market are focused on introducing innovative solutions, such as ON101, to gain a competitive edge in the market. Innovative solutions for diabetic foot ulcer treatment refer to new and advanced methods of managing and healing foot ulcers in individuals with diabetes. For instance, in October 2023, Oneness Biotech Co., a Taiwan-based pharmaceutical company, launched ON101, a novel treatment or cream (brand name Fespixon) that is used for topical treatment of DFUs (diabetic foot ulcers). ON101 cream is an effective treatment for chronic, non-healing DFUs that have failed to heal via conventional therapy. The results of clinical trials indicate that the wound-healing cream is beneficial for diabetic foot ulcers (DFUs). Participants in the study reported a 60% rate of complete healing over 16 weeks, which is higher than the 35% rate of healing with an absorbent wound dressing.

What Are Latest Mergers And Acquisitions In The Diabetic Foot Ulcer Treatment Market?

In August 2023, Coloplast, a Denmark-based company that develops products and services for people with medical conditions, acquired Kerecis for an undisclosed amount. As a result of the acquisition, both companies are now collaborating to advance and expand the availability of innovative solutions for patients with diabetic foot ulcers. Their combined product offerings provide diverse wound care approaches, giving healthcare professionals a broader selection of options to meet the specific needs of their patients. Kerecis is an Iceland-based company that provides treatment for diabetic foot ulcers using fish skin grafts.

Regional Outlook

North America was the largest region in the diabetic foot ulcer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetic Foot Ulcer Treatment Market?

The diabetic foot ulcer treatment market includes revenues earned by entities by ultrasound therapy, negative pressure wound therapy, and active therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetic Foot Ulcer Treatment Market Report 2026?

The diabetic foot ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot ulcer treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.